Kalisvaart Gijsbert M, Meijer Ruben P J, Bijlstra Okker D, Galema Hidde A, de Steur Wobbe O, Hartgrink Henk H, Verhoef Cornelis, de Geus-Oei Lioe-Fee, Grünhagen Dirk J, Schrage Yvonne M, Vahrmeijer Alexander L, van der Hage Jos A
Department of Surgical Oncology, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands.
Department of Radiology, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands.
Cancers (Basel). 2022 Mar 18;14(6):1572. doi: 10.3390/cancers14061572.
Optimal intraoperative tumor identification of gastrointestinal stromal tumors (GISTs) is important for the quality of surgical resections. This study aims to assess the potential of near-infrared fluorescence (NIRF) imaging with indocyanine green (ICG) to improve intraoperative tumor identification.
Ten GIST patients, planned to undergo resection, were included. During surgery, 10 mg of ICG was intravenously administered, and NIRF imaging was performed at 5, 10, and 15 min after the injection. The tumor fluorescence intensity was visually assessed, and tumor-to-background ratios (TBRs) were calculated for exophytic lesions.
Eleven GIST lesions were imaged. The fluorescence intensity of the tumor was visually synchronous and similar to the background in five lesions. In one lesion, the tumor fluorescence was more intense than in the surrounding tissue. Almost no fluorescence was observed in both the tumor and healthy peritoneal tissue in two patients with GIST lesions adjacent to the liver. In three GISTs without exophytic growth, no fluorescence of the tumor was observed. The median TBRs at 5, 10, and 15 min were 1.0 (0.4-1.2), 1.0 (0.5-1.9), and 0.9 (0.7-1.2), respectively.
GISTs typically show similar fluorescence intensity to the surrounding tissue in NIRF imaging after intraoperative ICG administration. Therefore, intraoperatively administered ICG is currently not applicable for adequate tumor identification, and further research should focus on the development of tumor-specific fluorescent tracers for GISTs.
胃肠道间质瘤(GIST)术中肿瘤的最佳识别对于手术切除质量至关重要。本研究旨在评估吲哚菁绿(ICG)近红外荧光(NIRF)成像改善术中肿瘤识别的潜力。
纳入10例计划行切除术的GIST患者。手术期间,静脉注射10mg ICG,并在注射后5、10和15分钟进行NIRF成像。对肿瘤荧光强度进行视觉评估,并计算外生性病变的肿瘤与背景比值(TBR)。
对11个GIST病变进行了成像。5个病变的肿瘤荧光强度在视觉上与背景同步且相似。在1个病变中,肿瘤荧光比周围组织更强。在2例GIST病变毗邻肝脏的患者中,肿瘤和健康腹膜组织几乎均未观察到荧光。在3个无外生性生长的GIST中,未观察到肿瘤荧光。5、10和15分钟时的TBR中位数分别为1.0(0.4 - 1.2)、1.0(0.5 - 1.9)和0.9(0.7 - 1.2)。
GIST在术中注射ICG后的NIRF成像中通常显示与周围组织相似的荧光强度。因此,术中注射ICG目前不适用于充分的肿瘤识别,进一步研究应聚焦于开发GIST特异性荧光示踪剂。